IMMUNORX PHARMA
ImmunoRx Pharma develops an anti-body that treats certain types of chronic inflammatory diseases including ulcerative colitis, rheumatoid arthritis, and Crohn’s disease. The company's antibody targets a new critical target in chronic inflammation and auto-immunity which was originally discovered by Dr. Tessier in Canada.
IMMUNORX PHARMA
Industry:
Health Care Medical Medical Device
Founded:
2020-01-01
Status:
Active
Total Funding:
2.67 M USD
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Equinox
Equinox is a developer of a medical technology in revolutionizing the treatment of glaucoma and other progressive eye diseases.
InTouch Health
InTouch Health is the leader in Acute Care Telemedicine solutions.
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Summit BHC
Summit Behavioral Healthcare is an Atlanta-based provider of addiction treatment and behavioral health services.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.